Literature DB >> 17114514

99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.

Fabio P Esteves1, Andrew Taylor, Amita Manatunga, Russell D Folks, Meghna Krishnan, Ernest V Garcia.   

Abstract

OBJECTIVE: Specific quantitative measurements have been recommended to assist in the interpretation of technetium-99m mercaptoacetyltriglycine (MAG3) renal studies. Our objective was to define the sex- and age-specific normal ranges for these recommended parameters.
MATERIALS AND METHODS: Data were obtained from a retrospective analysis of 106 subjects who were evaluated for kidney donation. The MAG3 clearance was calculated using a common camera-based method. The relative uptake, prevoid/postvoid and postvoid/maximum count ratios were determined using whole-kidney regions of interest (ROIs). Time to peak, time to half-peak, 20 min/maximum and 20 min/2-3 min count ratios were determined for cortical and whole-kidney ROIs. Residual urine volume was calculated on the basis of the pre- and postvoid bladder counts and voided urine volume.
RESULTS: The mean camera-based MAG3 clearance was 321 +/- 69 mL/min/1.73 m2, essentially the same as the mean plasma sample MAG3 clearance in comparable populations. The percentages of relative uptake in the right and left kidneys were 49% and 51% +/- 4%, respectively; no difference was seen between men and women. Cortical values were lower than the whole-kidney values (p < 0.001); the mean cortical 20 min/maximum count ratio was 0.19 (SD, 0.07 and 0.04 for right and left kidneys, respectively). The mean postvoid/maximum whole-kidney count ratio was < 0.1, and the mean postvoid residual bladder volume was < 30 mL.
CONCLUSION: Normal limits adjusted for age and sex have been established. Applying normal ranges to quantitative MAG3 parameters may assist in the interpretation of MAG3 scintigraphy and facilitate appropriate patient management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114514     DOI: 10.2214/AJR.05.1550

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

1.  Development and prospective evaluation of an automated software system for quality control of quantitative 99mTc-MAG3 renal studies.

Authors:  Russell D Folks; Ernest V Garcia; Andrew T Taylor
Journal:  J Nucl Med Technol       Date:  2007-03

2.  Evaluation of two diuresis renography decision support systems to determine the need for furosemide in patients with suspected obstruction.

Authors:  Andrew Taylor; Andrew N Hill; José N E Binongo; Amita K Manatunga; Raghuveer Halkar; Eva V Dubovsky; Ernest V Garcia
Journal:  AJR Am J Roentgenol       Date:  2007-05       Impact factor: 3.959

3.  SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.

Authors:  Andrew T Taylor; David C Brandon; Diego de Palma; M Donald Blaufox; Emmanuel Durand; Belkis Erbas; Sandra F Grant; Andrew J W Hilson; Anni Morsing
Journal:  Semin Nucl Med       Date:  2018-03-16       Impact factor: 4.446

4.  Automated patient motion detection and correction in dynamic renal scintigraphy.

Authors:  Russell D Folks; Daya Manatunga; Ernest V Garcia; Andrew T Taylor
Journal:  J Nucl Med Technol       Date:  2011-05-12

5.  Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation.

Authors:  Malgorzata Lipowska; Nashwa Jarkas; Ronald J Voll; Jonathon A Nye; Jeffrey Klenc; Mark M Goodman; Andrew T Taylor
Journal:  Nucl Med Biol       Date:  2017-12-27       Impact factor: 2.408

6.  99mTc-MAG3: Image Wisely.

Authors:  Andrew T Taylor; Russell D Folks; A K M Fazlur Rahman; Aruna Polsani; Eva V Dubovsky; Raghuveer Halkar; Amita Manatunga
Journal:  Radiology       Date:  2017-02-17       Impact factor: 11.105

7.  Guidance document for structured reporting of diuresis renography.

Authors:  Andrew T Taylor; M Donald Blaufox; Diego De Palma; Eva V Dubovsky; Belkis Erbaş; Anni Eskild-Jensen; Jørgen Frøkiær; Muta M Issa; Amy Piepsz; Alain Prigent
Journal:  Semin Nucl Med       Date:  2012-01       Impact factor: 4.446

8.  99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease.

Authors:  Andrew T Taylor; Malgorzata Lipowska; Hui Cai
Journal:  J Nucl Med       Date:  2013-02-19       Impact factor: 10.057

Review 9.  Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices.

Authors:  Andrew T Taylor
Journal:  J Nucl Med       Date:  2014-02-18       Impact factor: 10.057

10.  Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.

Authors:  Malgorzata Lipowska; Jeffrey Klenc; Russell D Folks; Andrew T Taylor
Journal:  Nucl Med Mol Imaging       Date:  2014-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.